Skip to main content
NAGE logo
NAGE
(NASDAQ)
Niagen Bioscience, Inc.
$3.31-- (--)
Loading... - Market loading

Niagen Bioscience (NAGE) Stock Price & Financial Analysis

Niagen Bioscience Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.38 - $3.57
52-Week High$14.69
52-Week Low$3.35
Open$3.39
Volume562.97K
Average Volume (3M)909.82K
Market Cap288.37M
Shares Outstanding84.57M
P/E Ratio (TTM)15.47
Forward P/E11.83
Price to Sales (P/S)2.21
Price to Book (P/B)3.50
EV/EBITDA11.06
Revenue (TTM)130.42M
Net Income (TTM)18.64M
Free Cash Flow (TTM)4.05M
EPS (TTM)$0.22
Profit Margin14.29%
Operating Margin8.51%
Return on Equity (ROE)22.64%
Debt to Equity0.03
50-Day MA$4.09
200-Day MA$5.95
52-Week Change-74.63%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Niagen Bioscience

What is the current stock price for NAGE?

As of the latest trading session, NAGE stock trades at $3.45. The 52-week range is $3.35–$14.69, with a day range of $3.38–$3.56.

What is the P/E ratio for NAGE?

Niagen Bioscience's trailing P/E ratio is 15.5, meaning investors pay $15.5 for every $1 of annual earnings. The forward P/E is 11.8, reflecting analyst expectations for future earnings. Niagen Bioscience operates in the Healthcare sector.

Does NAGE pay dividends?

Niagen Bioscience does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NAGE?

Based on 1 analyst, the consensus for NAGE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NAGE?

Niagen Bioscience's market capitalization is $291.8M, classifying it as a micro-cap company. Niagen Bioscience operates in the Healthcare sector within the Biotechnology industry.